Skip to main content

Table 1 Baseline Demographic and Ocular Characteristics

From: Second-generation trabecular micro-bypass stent implantation: Retrospective analysis after 12- and 24-month follow-up

 

Total

POAG

PEX

NTG

OH

Number

 patients

109

54

28

12

15

 eyes

164

84

42

18

20

Age (years)

 Mean ± SD

76.7 ± 6.8

76.6 ± 7.5

77.3 ± 4.7

79.3 ± 6.5

73.6 ± 7.6

Sex

 male

48

27

11

6

4

 female

61

27

17

6

11

Eye

 OD

85

42

21

11

11

 OS

79

42

21

7

9

History of glaucoma surgery (# of eyes)

8

4

3

0

1

IOP (12-month cohort)

 N

164

84

42

18

20

 Mean (mmHg)

20.0

20.2

20.3

17.1

21.3

 SD

5.5

5.6

4.9

5.4

5.6

IOP (24-month cohort)

 N

88

46

19

10

13

 Mean (mmHg)

20.3

20.3

21.7

17.3

20.7

 SD

6.1

6.1

6.1

5.5

6.2

Medications (12-month cohort)

     

N

164

84

42

18

20

Mean

2.0

2.1

2.1

1.7

1.5

SD

1.0

1.0

1.0

0.9

1.0

Medications (24-month cohort)

     

N

88

46

19

10

13

Mean

2.05

2.13

2.21

1.90

1.62

SD

1.09

1.13

1.18

0.74

1.04

Eyes on

 0 med

3 (1.8%)

0 (0%)

0 (0%)

0 (0%)

3 (15.0%)

 1–2 med

108 (65.8%)

55 (65.5%)

25 (59.5%)

15 (83.3%)

13 (65.0%)

  ≥ 3 med

53 (32.4%)

29 (34.5%)

17 (40.5%)

3 (16.7%)

4 (20.0%)

N (%)

     

CDVA (N)

164

84

42

18

20

 Mean LogMAR

0.39

0.41

0.36

0.43

0.35

 SD

0.17

0.18

0.14

0.17

0.17

C/D ratio

 Mean

0.55

0.61

0.54

0.55

0.30

 SD

0.24

0.21

0.25

0.24

0.20

  1. POAG = primary open angle glaucoma; PEX = pseudoexfoliation glaucoma; NTG = normal tension glaucoma; OH = ocular hypertension; IOP = intraocular pressure; CDVA = corrected distance visual acuity; SD = standard deviation